EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Comment on “Pyrotinib combined with trastuzumab and chemotherapy in the treatment of HER2-positive metastatic breast cancer after the progression of trastuzumab therapy”

Madhuri Sathyanarayana

Journal of the Formosan Medical Association · 2026-05

DOI: 10.1016/j.jfma.2026.05.033 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the Formosan Medical Association, 2026-05. Verfasst von Madhuri Sathyanarayana. Beteiligte Einrichtung: Department of PG Studies and Research in Biochemistry, Kuvempu University, Karnataka, India. Electronic address: researcherscientific629@gmail.com. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ChemotherapyHER2-Positive breast cancerMetastatic breast cancerProgression-free survivalPyrotinibTrastuzumab

Autor:innen und Institutionen

  • Department of PG Studies and Research in Biochemistry, Kuvempu University, Karnataka, India. Electronic address: researcherscientific629@gmail.com.

Zitieren

APA

Sathyanarayana, M. (2026). Comment on “Pyrotinib combined with trastuzumab and chemotherapy in the treatment of HER2-positive metastatic breast cancer after the progression of trastuzumab therapy”. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2026.05.033

Vancouver

Sathyanarayana M. Comment on “Pyrotinib combined with trastuzumab and chemotherapy in the treatment of HER2-positive metastatic breast cancer after the progression of trastuzumab therapy”. Journal of the Formosan Medical Association. 2026. doi:10.1016/j.jfma.2026.05.033

BibTeX
@article{Sathyanarayana2026,
  author = {Sathyanarayana, Madhuri},
  title = {Comment on “Pyrotinib combined with trastuzumab and chemotherapy in the treatment of HER2-positive metastatic breast cancer after the progression of trastuzumab therapy”},
  journal = {Journal of the Formosan Medical Association},
  year = {2026},
  doi = {10.1016/j.jfma.2026.05.033}
}
Kostenlos starten →